Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study of the Efficacy, Safety, and Pharmacoeconomics of Oral Ibandronate (Bondronat 50 mg) in Treatment of Metastatic Bone Disease

NCT02564107 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02564107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02564107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study of the Efficacy, Safety, and Pharmacoeconomics of Oral Ibandronate (Bondronat 50 mg) in Treatment of Metastatic Bone Disease
Lead sponsor
Hoffmann-La Roche
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2004
Completion date
April 30, 2006
Enrollment
48 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

pain; bone neoplasms; neoplasm metastasis